A kind of preparation method of zolmitriptan intermediate
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 济南立德医药技术有限公司
- Publication Date
- 2021-04-06
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the technical field of organic synthesis, and in particular relates to a preparation method of a zolmitriptan intermediate. Background technique
[0002] Zolmitriptan, chemical name (S)-4-[3-[2-(dimethylamino)ethyl]-1H-indole-5-methyl]-2-oxazolidinone, is An anti-migraine drug developed by Glaxo-Wellcome in Germany, it is a highly selective serotonin (5-TH1B and 5-TH1D) receptor agonist, which stimulates intracranial blood vessels (including arteriovenous anastomosis) ) and 5-HTIB / ID receptors on the sympathetic nerves of the trigeminal nervous system, constrict blood vessels and inhibit the release of neuropeptides to relieve migraine attacks. At present, it has been listed in the United Kingdom, the United States and other countries, and the market prospect is good.
[0003] (S)-4-(4-aminobenzyl)-2-oxazolidinone is an important intermediate in the synthesis of zolmitriptan. At present, (S)-4-(4-aminobenzyl)-2-oxazolidinone...